These results indicated that the CCR9 expression might be predictive for lymph node metastasis in patients with lung adenocarcinoma, therefore more aggressive treatment should be considered in the patients at high risk of lymph node metastasis. This evidence concerns the gene CCR9 and metastatic malignant neoplasm in the lymph nodes.